Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative ColitisPRESS RELEASE – For UK consumer health, medical and trade media onlyRisankizumab will be ...
Peruvian researchers studied a small group of medical students and found that IBS sufferers had a 108% higher prevalence of ED than those without the chronic gastrointestinal disorder.